NCT00094029 2012-03-09A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248PfizerApproved for marketing
NCT00130897 2012-03-09Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell CarcinomaPfizerApproved for marketing